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A B S T R A C T
Diabetic cystoid macular oedema (DME) is a common cause of visual acuity (VA) decrease. Good anatomical results
and VA of pars plana vitrectomy (PPV) in cases of macular hole internal limiting membrane (ILM) peeling leads to usage
of this technique in DME. A favorable result even in a case without vitreoretinal traction leads to conclusion that patho-
genesis of this disease is different. We analyzed retrospectively 20 eyes from 20 patients with DME that had undergone
PPV and ILM peeling. Half of them were laser treated 6 months before surgery. All eyes had an attached posterior hya-
loids membrane in the macular region, but without thickening and without traction. Median duration of DME at the
time of PPV was 18 months (range 12–24 months). The median preoperative best-corrected VA of 0.4 (range 0.01–1.0),
improved to a median postoperative VA of 0.55 (range 0.01–1.0). Ten eyes without preoperative laser coagulation had a
median VA improvement of 77%, while 10 eyes with preoperative macular laser treatment had a median VA improvement
of 14.8%. In all 20 eyes DME was no longer visible on microscopic examination after a median period of 3 months after
PPV. PPV and ILM peeling resulted in the resolution of oedema, with an improvement in VA in the majority of cases.
Eyes without preoperative macular photocoagulation had a significantly higher visual improvement than eyes with pre-
operative laser treatment. A randomized controlled prospective trial of PPV versus laser is needed to determine the role of
PPV as a treatment modality for DME.
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Introduction
Macular oedema is present in various general and
ophthalmologic disorders and is the most frequent cause
of decreased vision acuity (VA). It is also encountered as
a complication of diabetic retinopathy. Etiology is com-
plex. Impairment of hematoretinal barrier and impaired
blood supply to retina are included among the causes.
Another possible cause is an early ageing of the vitreous
body in diabetic patients, which is manifested by mor-
phological and biochemical changes. Migration of glial
and epithelial cells on the vitreoretinal border with a pro-
duction of epiretinal membranes in the central area,
which is morphologically manifested as a cystoid macular
oedema (CME), was described but not always with vit-
reomacular traction, however. Ischemia of the central re-
gion of retina1,2 results in production of humoral sub-
stances like vascular endothelial growth factor (VEGF)
and interleukin (IL-6, IL-8). Observations of some
authors3 who report occurrence of macular oedema in di-
abetic patients without obvious traction as well as a
possibility of spontaneous healing after detachment of
the posterior vitreous body also support this version. It is
not clear if pars plana vitrectomy (PPV) heals CME
alone, or has an additional effect on laser treated eyes.
The object of this study is comparison of clinical results
in both groups.
Materials and Methods
For the purpose of this study, we dealt with patients
with clinically significant diabetic macular oedema (DME)
without other eye pathology. We divided the patients in
two groups: 10 patients were treated with focal laser co-
agulation at least 6 months prior to surgery and 10 pa-
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tients with the same pathology without laser coagulation
of the central region performed. All patients signed the
informed consent prior to the procedure. The diagnosis
of CME was confirmed by biomicroscopy and OCT or
HRT II examination. No patient had a vitreoretinal
macular traction. All patients suffered from type 2 diabe-
tes mellitus. Patients were treated with PPV with peel-
ing of the internal limiting membrane (ILM). The clini-
cal condition of patients was further observed 12–36
months after the procedure.
Results
Age and gender distribution in both groups was simi-
lar (Table 1). Clinical data of treated patients are pre-
sented in Tables 2 and 3. Median of macular oedema in
the time of PPV was 11 months (ranging 2–36). Throu-
ghout a 12-month period flattening of retina and disap-
pearance of cystic changes in macula were observed in all
patients. Ophthalmologic findings always stabilized; more
significant improvement of ocular functions was obser-
ved in the group of patients without previous laser coag-
ulation. This finding is statistically significant for PPV
group but not for PPV and laser group (Table 4).
Discussion and Conclusion
Kishi and Shimizu described the morphology of pre-
-macular vitreous body for the first time4. Gandorfer et
al. properly analyzed samples of vitreoretinal border in
patients with diabetic retinopathy and chronic macular
oedema and found that in diabetic patients, even in case
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TABLE 1
PATIENTS BY GENDER AND AGE
Characteristic Laser + PPV* group Only PPV* group
Male:female ratio 7:3 2:8
Age
X ± SD 59.7 ± 11.3 66.4 ± 8.8
Range 36–76 53–76
* PPV – pars plana vitrectomy
TABLE 2











1 64/f/r 0.6 320 1 None 24
2 61/m/l 0.16 450 0.6 None 18
3 74/f/l 0.02 500 0.33 Hard exudates 22
4 75/f/l 0.16 420 0.16 Hard exudates 12
5 72/f/r 0.16 380 0.33 None 16
6 53/f/r 0.01 520 0.01 Hard exudates 21
7 76/f/r 0.01 510 0.3 Cataracta 18
8 55/f/l 0.16 511 0.16 Cataracta 24
9 60/m/r 0.01 480 0.16 Hard exudates 14
10 74/f/r 0.16 370 0.16 Hard exudates 16
TABLE 3











1 60/m/r 0.6 280 1 Cataracta 18
2 50/m/r 1 220 1 None 12
3 57/m/l 0.3 360 0.25 Cataracta 20
4 60/m/r 0.6 420 0.5 None 16
5 68/f/l 0.5 390 0.6 None 18
6 76/f/l 0.5 350 0.6 None 15
7 72/f/r 1 240 1 None 23
8 36/m/l 0.6 400 1 None 15
9 57/m/l 0.6 420 1 Open angle glaucoma 24
10 61/m/r 1 240 1 None 24
of vitreous body detachment, there is collagen fibers
bound to ILM in the pre-macular region5. They expre-
ssed a theory that ablation of the posterior vitreous body
does not occur in the level of ILM. Our results support
this theory. It seems that for a successful result of the
surgery, it is necessary to remove ILM, also. This conclu-
sion is supported by the regression of macular oedema
also in patients where it was impossible to remove ILM
completely during the surgery. The same opinion share
many vitreoretinal surgeons. Focal laser coagulation in
CME is a proven standard according to a multi-centric
study EDTRS.
Considering that own collagen of the vitreous body
has no contractile abilities, attention is paid mainly on
cells, in which contractile fibers were proven. Participa-
tion of cell membrane together with pathological colla-
gen fibers is necessary for the occurrence of tangential
traction of the macular retina. In our material, we did
not find continuous cell membranes and corresponding
OCT finding. This would support the above mentioned
humoral and ischemic theory. The same conclusion was
expressed by Gandorfer et al.5. The effect of other factors
besides mechanical traction of epiretinal tissue may be
assumed in the etiology of DME. Funatsu et al.6–8 and
Aiello et al.9 independently expressed a hypothesis that,
in the vitreous body of diabetic patients, there are humo-
ral substances like VEGF and IL-6 produced in the cells
of epiretinal membranes, which impair hematoocular
barrier and contribute to the development of macular oe-
dema. Regression of macular oedema after PPV may be
explained also by a decrease or removal of the above fac-
tors with vitrectomy10. This hypothesis is also supported
by the gradual post-operative regression of CME. The ef-
ficiency of epimacular tissue removal and pathogenesis
of macular oedema is till a subject to discussions11. Theo-
retically, it can be assumed that PPV results in loosening
of traction forces and removal of factors increasing per-
meability. The benefit may also be an improved supply of
macula with oxygen and nutritive substances. ILM peel-
ing furthermore facilitates removal of epimacular patho-
logical tissue and core of the vitreous body.
PPV and posterior limiting membrane peeling in dia-
betic retinopathy without obvious traction may result in
regression of clinically significant CME and improve-
ment of VA. Patients who were not treated with laser had
a better improvement of post-operative VA. Follow-up
randomized studies of the efficiency of simple PPV with
membrane peeling compared to the therapy with focal la-
ser coagulation will be necessary12. Good functional re-
sults despite adverse vitreoretinal traction may be caused
also by a different pathogenesis of the disorder compared
with the surgery of the true macular hole.
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TABLE 4
STATISTICS OF VISUAL ACUITY IN BOTH GROUPS
Visus Mean Mean SD** Number of patients Differences SD** t*** sv p-value
Group laser + PPV* Before 0.625 0.22
10 0.031 0.11 0.88 9 0.40
After 0.594 0.25
Group PPV* Before 0.181 0.19
10 –0.155 0.17 –2.82 9 0.02
After 0.336 0.28
* PPV – pars plana vitrectomy, ** SD – standard deviation, *** T-test (Student test) for dependent samples was used,
statistical significance at p<0.05
KRONI^NI DIJABETI^KI MAKULARNI EDEM, ODSTRANJIVANJE GLATKOG DIJELA
STAKLASTOG TIJELA (ENGL.PARS PLANA VITRECTOMY) ILI KOMBINACIJA PPV-A I LASERA?
S A @ E T A K
Dijabeti~ki cisti~ni makularni edem (DME) uobi~ajen je razlog smanjenja o{trine vida (engl. visual acuity (VA)).
Dobri rezultati u anatomiji i o{trini vida kod odstranjivanja glatkog dijela staklastog tijela (PPV) u slu~ajevima odva-
janja makule od stra`njeg segmenta (engl. ILM peeling) dovode do upotrebe ove tehnike kod dijagnoze DME-a. Dobri
rezultati ~ak i u slu~ajevima bez povla~enja retine od staklastog tijela dovode do zaklju~ka kako je patogeneza ove
bolesti razli~ita. U ovom smo istra`ivanju prou~avali 20 o~iju od 20 pacijenata s dijagnosticiranim DME-om koji su bili
podvrgnuti PPV- u i ILM odvajanju. Polovica ispitanika bila je tretirana laserski 6 mjeseci prije operacije. Sve su o~i
imale stra`nju hijaloidnu membranu u makularnoj regiji, ali bez zadebljanja ili povla~enja. Prosje~no trajanje DME-a u
trenutku PPV-a bilo je 18 mjeseci (u rasponu od 12–24 mjeseci). Prosje~no preoperativno najbolje ispravljen VA od 0,4
(u rasponu od 0,01–1,0), pobolj{ao se do prosje~nog postoperativnog VA od 0.55 (u rasponu od 0.01–1.0). Deset o~iju bez
laserske preoperativne koagulacije imale su VA pobolj{anje od 77%, dok je 10 o~iju s preoperativnim makularnim laser-
skim tretmanom imalo prosje~no VA pobolj{anje od 14,8%. Kod svih 20 o~iju 3 mjeseca nakon PPV, DME mikroskop-
skim pregledom vi{e nije bio uo~ljiv. PPV i ILM odvajanje rezultirali su nestajanjem edema i pobolj{anjem o{trine vida u
ve}ini slu~ajeva. O~i bez preoperativne makularne fotokoagulacije imale su zna~ajno ve}e vidno pobolj{anje u odnosu
na o~i s laserskim preoperativnim zahvatom. Potrebne su nasumi~ne kontrolirane studije PPV-a u odnosu na laserske
tretmane kako bi se utvrdila uloga PPV-a kao zamjenske terapije u tretiranju DME-a.
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